MTOR and breast carcinoma: Ajabnoor et al. reported that an increased autophagic response was observed in paclitaxel-resistant MCF-7 breast cancer cells with reduced phosphor-mTOR and a relative resistance to the mTOR inhibitors rapamycin and RAD001 [53], suggesting that autophagy may act as a survival mechanism in paclitaxel-resistant breast cancer cells.